Osstem Implant, a South Korea-based dental implant maker, is in advanced discussions to buy ZimVie (ZIMV), Bloomberg’s Vinicy Chan reports. According to people familiar with the matter, financing is in place. ZimVie, which was spun off from Zimmer Biomet (ZBH) in 2022, has been working with an adviser after receiving interest from potential buyers and had a market value of about $517M as of Wednesday.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZIMV: